Literature DB >> 20407122

TRIM proteins: another class of viral victims.

Muhammad Munir1.   

Abstract

TRIM (tripartite motif) proteins are a family of RING (really interesting new gene) domain-containing proteins comprising more than 70 human members, with new members still being described. In addition to their involvement in cell proliferation, differentiation, development, morphogenesis, and apoptosis, roles in immune signaling and antiviral functions are emerging. In response to viral infection, TRIM25 ubiquitinates the N terminus of the viral RNA receptor retinoic acid-inducible gene-I (RIG-I), and this modification is essential for RIG-I to interact with its downstream partner mitochondrial antiviral signaling (MAVS). TRIM25 activity thus leads to activation of the RIG-I signaling pathway, which results in type I interferon production to limit viral replication. Recently, it has been demonstrated that influenza A viruses target TRIM25 and disable its antiviral function, thereby suppressing the host interferon response. This Journal Club article highlights the emerging roles of TRIM proteins in antiviral defense mechanisms and an immune evasion strategy in which influenza viruses target a member of the TRIM family.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20407122     DOI: 10.1126/scisignal.3118jc2

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  40 in total

1.  TRIM56 is a virus- and interferon-inducible E3 ubiquitin ligase that restricts pestivirus infection.

Authors:  Jie Wang; Baoming Liu; Nan Wang; Young-Min Lee; Chunming Liu; Kui Li
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

2.  The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.

Authors:  Yong Hu; Wei Li; Ting Gao; Yan Cui; Yanwen Jin; Ping Li; Qingjun Ma; Xuan Liu; Cheng Cao
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

3.  A host lncRNA regulates the innate immune response to an RNA virus.

Authors:  Kiyoharu Fukushima; Hiroshi Kida
Journal:  Cell Mol Immunol       Date:  2019-08-29       Impact factor: 11.530

4.  TRIM56 is an essential component of the TLR3 antiviral signaling pathway.

Authors:  Yang Shen; Nan L Li; Jie Wang; Baoming Liu; Sandra Lester; Kui Li
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

5.  Tripartite motif ligases catalyze polyubiquitin chain formation through a cooperative allosteric mechanism.

Authors:  Frederick C Streich; Virginia P Ronchi; J Patrick Connick; Arthur L Haas
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

6.  Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus.

Authors:  Baoming Liu; Nan L Li; Jie Wang; Pei-Yong Shi; Tianyi Wang; Mark A Miller; Kui Li
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

7.  Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells.

Authors:  Mustimbo E P Roberts; Denise Kaminski; Scott A Jenks; Craig Maguire; Kathryn Ching; Peter D Burbelo; Michael J Iadarola; Alexander Rosenberg; Andreea Coca; Jennifer Anolik; Iñaki Sanz
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

Review 8.  Emerging role of ubiquitination in antiviral RIG-I signaling.

Authors:  Jonathan Maelfait; Rudi Beyaert
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

Review 9.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

10.  Trim14 overexpression causes the same transcriptional changes in mouse embryonic stem cells and human HEK293 cells.

Authors:  Valentina V Nenasheva; Galina V Kovaleva; Nella V Khaidarova; Ekaterina V Novosadova; Ekaterina S Manuilova; Stanislav A Antonov; Vyacheslav Z Tarantul
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-10-03       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.